Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Cunningham

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|May 12, 2011
Driving operational excellence across researchMark R Cunningham
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|November 19, 2011
Evaluation of closed incision management with negative pressure wound therapy (CIM): hematoma/seroma and involvement of the lymphatic systemDeepak V Kilpadi, Mark R Cunningham
Surgical Innovation|September 15, 2011
Burst strength testing of porcine intestinal anastomoses following negative pressure therapyKenneth C Norbury, Deepak V Kilpadi, Barbara A Collins, et al.
Environmental Microbiology Reports|January 23, 2021
Comparative genomics analyses indicate differential methylated amine utilization trait within members of the genus GemmobacterEileen Kröber, Mark R Cunningham, Julianna Peixoto, et al.
Mbio|May 16, 2022
The Proteobacterial Methanotroph <i>Methylosinus trichosporium</i> OB3b Remodels Membrane Lipids in Response to Phosphate LimitationJulie Scanlan, Richard Guillonneau, Mark R Cunningham, et al.
Protein Expression and Purification|November 3, 2007
Expression and characterization of a human BMP-7 variant with improved biochemical propertiesBethany Swencki-Underwood, Juliane K Mills, Joe Vennarini, et al.
Neurosurgery|October 14, 2006
Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessmentElad I Levy, Ricardo A Hanel, Fermin O Tio, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2005
Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeysJeannie R Rojas, Ronald P Taylor, Mark R Cunningham, et al.
Cytokine|June 6, 2006
Engineering human IL-18 with increased bioactivity and bioavailabilityBethany Swencki-Underwood, Mark R Cunningham, George A Heavner, et al.
Diabetes|April 23, 2008
Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasisKristen M Picha, Mark R Cunningham, Daniel J Drucker, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|May 12, 2011
Driving operational excellence across researchMark R Cunningham
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|November 19, 2011
Evaluation of closed incision management with negative pressure wound therapy (CIM): hematoma/seroma and involvement of the lymphatic systemDeepak V Kilpadi, Mark R Cunningham
Surgical Innovation|September 15, 2011
Burst strength testing of porcine intestinal anastomoses following negative pressure therapyKenneth C Norbury, Deepak V Kilpadi, Barbara A Collins, et al.
Environmental Microbiology Reports|January 23, 2021
Comparative genomics analyses indicate differential methylated amine utilization trait within members of the genus GemmobacterEileen Kröber, Mark R Cunningham, Julianna Peixoto, et al.
Mbio|May 16, 2022
The Proteobacterial Methanotroph <i>Methylosinus trichosporium</i> OB3b Remodels Membrane Lipids in Response to Phosphate LimitationJulie Scanlan, Richard Guillonneau, Mark R Cunningham, et al.
Protein Expression and Purification|November 3, 2007
Expression and characterization of a human BMP-7 variant with improved biochemical propertiesBethany Swencki-Underwood, Juliane K Mills, Joe Vennarini, et al.
Neurosurgery|October 14, 2006
Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessmentElad I Levy, Ricardo A Hanel, Fermin O Tio, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2005
Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeysJeannie R Rojas, Ronald P Taylor, Mark R Cunningham, et al.
Cytokine|June 6, 2006
Engineering human IL-18 with increased bioactivity and bioavailabilityBethany Swencki-Underwood, Mark R Cunningham, George A Heavner, et al.
Diabetes|April 23, 2008
Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasisKristen M Picha, Mark R Cunningham, Daniel J Drucker, et al.
Pageof 2